IMDXVSSGRX• 28 Days (Normalized)
IMDX vs SGRX (Insight Molecular Diagnostics Inc. vs SANGRIX INC.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IMDX Performance $4.2
-2.78%
Insight Molecular Diagnostics Inc.
Normalized Baseline0.00%
SGRX Performance $1.68
-59.02%
SANGRIX INC.
Normalized Baseline0.00%
Alpha Spread Margin IMDX LEADS
+56.24%
IMDX outperforming by 56.24%
IMDXSGRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IMDX SGRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | IMDX Price | IMDX Gain (%) | SGRX Price | SGRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $4.20 | -2.78% | $1.68 | -59.02% | +56.24% |
| Sep 10, 2026 | $3.98 | -7.87% | $1.43 | -65.12% | +57.25% |
| Sep 09, 2026 | $4.10 | -5.09% | $1.66 | -59.51% | +54.42% |
| Sep 08, 2026 | $4.27 | -1.16% | $1.64 | -60.00% | +58.84% |
| Sep 04, 2026 | $4.13 | -4.40% | $2.10 | -48.78% | +44.38% |
| Sep 03, 2026 | $4.12 | -4.63% | $2.21 | -46.10% | +41.47% |
| Sep 02, 2026 | $4.01 | -7.18% | $2.32 | -43.41% | +36.23% |
| Sep 01, 2026 | $3.84 | -11.11% | $2.58 | -37.07% | +25.96% |
| Aug 31, 2026 | $3.92 | -9.26% | $2.77 | -32.44% | +23.18% |
| Aug 28, 2026 | $4.13 | -4.40% | $3.10 | -24.39% | +19.99% |
| Aug 27, 2026 | $4.29 | -0.69% | $3.55 | -13.41% | +12.72% |
| Aug 26, 2026 | $4.30 | -0.46% | $3.42 | -16.59% | +16.13% |
| Aug 25, 2026 | $4.44 | +2.78% | $3.62 | -11.71% | +14.49% |
| Aug 24, 2026 | $4.32 | +0.00% | $3.32 | -19.02% | +19.02% |
| Aug 21, 2026 | $4.34 | +0.46% | $3.73 | -9.02% | +9.48% |
Page 1 of 2